eFFECTOR Therapeutics, Inc. Unrecognized Tax Benefits, Period Increase (Decrease)
eFFECTOR Therapeutics, Inc. reported Unrecognized Tax Benefits, Period Increase (Decrease) of $793.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-26.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2024-03-26
- eFFECTOR Therapeutics, Inc. unrecognized tax benefits, period increase (decrease) for fiscal 2023 was $793.00K, a 35.32% increase from fiscal 2022.
- eFFECTOR Therapeutics, Inc. unrecognized tax benefits, period increase (decrease) for fiscal 2022 was $586.00K, a 2.99% increase from fiscal 2021.
- eFFECTOR Therapeutics, Inc. unrecognized tax benefits, period increase (decrease) for fiscal 2021 was $569.00K, a 20.04% increase from fiscal 2020.
- eFFECTOR Therapeutics, Inc. unrecognized tax benefits, period increase (decrease) for fiscal 2020 was $474.00K.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 12 month |
|---|---|
| 2023-12-31 | $793.00K 10-K · filed 2024-03-26 |
| 2022-12-31 | $586.00K 10-K · filed 2024-03-26 |
| 2021-12-31 | $569.00K 10-K · filed 2023-03-08 |
| 2020-12-31 | $474.00K 10-K · filed 2022-03-16 |